NCATS and FDA Hold Workshop on Assay Development for High Throughput Screening

Home / Community Blog / NCATS and FDA Hold Workshop on Assay Development for High Throughput Screening

Community Blog

NCATS and FDA Hold Workshop on Assay Development for High Throughput Screening

Contributor: Catherine Sprankle, NICEATM

The National Center for Advancing Translational Sciences (NCATS) and the U.S. Food and Drug Administration (FDA) will hold a workshop on April 5-6, 2016, at the Harvey W. Wiley Federal Building in College Park, Maryland, for scientists involved in assay development for high throughput screening and lead optimization. The goal of the workshop is to share best practices and provide advice for robust assay design and development. During the two-day workshop, drug discovery experts will cover a broad range of critical concepts underlying assay development and lead discovery strategies. The workshop is designed to disseminate critical information about the implementation of robust assay methods that can benefit the entire drug discovery community.

View more information and register for the workshop

Catherine Sprankle
Catherine Sprankle
Communications Specialist for NICEATM